Author:
SUSAN JOSEPH ,SAINATHAN R
Abstract
Objectives: The objectives of the study were to analyze the prescribing pattern in COVID-19 patients and to identify the most commonly prescribed drugs and their routes.
Methods: A hospital-based retrospective observational study was conducted based on data of COVID-19 positive patients admitted over a period of 6 months, from May 1, 2020, to October 31, 2020. Relevant data were collected from medical records library.
Results: The prescriptions of 1223 COVID-19 positive patients were analyzed. Among them 63.7% were men (n=780). The mean age was 46.5 years. 49.9% (n=611) of our patients were mild cases, categorized as category A. 41.2% (n=505) were category B, and 8.7% came under the severe disease category C. Duration of hospital stay of the patients ranged from 1 to 44 days with a mean duration of 9 days. The most prescribed medication was paracetamol which was prescribed to 55% (n=679) of patients. From the 488 (39.9%) patients who received some antibiotic, the most frequently prescribed was azithromycin (80.1%) followed by ceftriaxone (17.2%) and cefotaxime (3.07%). 18.5% of patients were prescribed anticoagulants, the most common being LMWH-enoxaparin. 17.9% of patients received some systemic corticosteroids. Antivirals prescribed were favipiravir (7.4%), oseltamivir (4.7%), and 0.8% remdesivir.
Conclusion: Different drugs belonging to different groups have been prescribed, for symptomatic treatment of disease and its complications as a single effective drug has not been discovered. Almost all the drugs prescribed were generic drugs and were from the Essential List of Medicines-2015.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference26 articles.
1. Hui DS, Madani TA, Ntoumi F, Kock R, Dar O, Kock R, et al. The continuing 2019-nCoV epidemic threat of novel Coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264-6. doi: 10.1016/j.ijid.2020.01.009, PMID 31953166
2. Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel Coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS One 2020;15:e0234765. doi: 10.1371/journal.pone.0234765, PMID 32574165, PMCID 7310678
3. Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA 2020;323:1499-500. doi: 10.1001/jama.2020.3633, PMID 32159735
4. World Health Organization. Statement on the Second Meeting of the International Health Regulations. Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV). Geneva: World Health Organization; 2005.
5. Covid-19 Body Count: India’s Low Mortality Rate and the Contrasting Pictures of Two States. News. Available from: https://www.news18. com/news/india/covid-19-body-count-indias-low-mortality-rate-and-the-contrasting-pictures-of-two-states-2578653.html [Retrieved on 2020 Apr 16], [Last accessed on 2023 Mar 20].